Reports for HIKMA CANADA LIMITED
Company Name
HIKMA CANADA LIMITED
Totals |
||
Shortage reports |
104 |
|
| Actual shortage: | 20 (19%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (1%) | |
| Resolved: | 83 (80%) | |
Discontinuation Reports |
9 |
|
| To be discontinued: | 3 (33%) | |
| Discontinued: | 6 (67%) | |
| Reversed: | 0 (0%) | |
Late reports |
16 (14%) |
|
Overdue reports |
17 (74%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CEFUROXIME FOR INJECTION, USP | 750MG | POWDER FOR SOLUTION | Actual shortage | 2020-08-13 | 2020-10-31 | 122228 |
| CYANOCOBALAMIN INJECTION USP | 1000MCG | SOLUTION LIQUID | Actual shortage | 2024-11-13 | 2025-02-19 | 242881 |
| CYANOCOBALAMIN INJECTION USP | 1000MCG | SOLUTION LIQUID | Resolved | 2023-08-03 | 2023-12-15 | 200983 |
| CYANOCOBALAMIN INJECTION USP | 1000MCG | LIQUID | Resolved | 2019-10-03 | 2020-02-04 | 95366 |
| DANTROLENE SODIUM FOR INJECTION, USP | 20MG | POWDER FOR SOLUTION | Resolved | 2024-06-26 | 2024-09-03 | 231326 |
| DIAZEPAM INJECTION USP | 5MG | SOLUTION | Resolved | 2018-09-27 | 2019-05-04 | 62442 |
| DIAZEPAM INJECTION USP | 5MG | SOLUTION | Actual shortage | 2020-05-20 | 2020-05-21 | 115413 |
| DIMENHYDRINATE INJECTION USP | 50MG | SOLUTION | Resolved | 2022-04-14 | 2022-06-07 | 158877 |
| DIMENHYDRINATE INJECTION USP | 50MG | SOLUTION | Resolved | 2023-11-17 | 2024-09-03 | 210671 |
| DIMENHYDRINATE INJECTION USP | 50MG | SOLUTION | Resolved | 2018-02-15 | 2018-05-16 | 39961 |
| ENALAPRILAT INJECTION USP | 1.25MG | SOLUTION | Resolved | 2024-06-26 | 2025-05-08 | 231317 |
| ENALAPRILAT INJECTION USP | 1.25MG | SOLUTION | Resolved | 2023-12-19 | 2024-05-24 | 213843 |
| ENALAPRILAT INJECTION USP | 1.25MG | SOLUTION | Resolved | 2017-07-31 | 2017-09-13 | 17559 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2017-12-22 | 2018-07-09 | 34254 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2019-12-20 | 2020-02-21 | 101864 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2019-01-22 | 2019-01-30 | 73273 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2018-09-27 | 2018-11-30 | 62439 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2019-02-19 | 2019-06-19 | 76329 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2022-03-30 | 2022-04-28 | 157571 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2023-08-03 | 2024-03-28 | 200978 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | 0.2% | SOLUTION | Discontinued | 2025-03-24 | 2025-04-07 | 253339 |
| BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | 0.2% | SOLUTION | Discontinued | 2025-03-24 | 2025-04-02 | 253342 |
| DORZOLAMIDE AND TIMOLOL EYE DROPS BP | 5MG 20MG | SOLUTION | Discontinued | 2024-11-01 | 2024-11-01 | 241852 |
| LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION | 5MG 50MCG | SOLUTION | Discontinued | 2024-10-01 | 2024-10-02 | 239073 |
| LATANOPROST OPHTHALMIC SOLUTION | 50MCG | SOLUTION | Discontinued | 2025-03-24 | 2025-04-02 | 253336 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Discontinued | 2024-04-19 | 2024-04-22 | 225805 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165188 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165193 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165196 |
Showing 1 to 9 of 9